These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28818087)

  • 1. Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention.
    Liebenberg LJP; Archary D; Sivro A; Kwon DS
    Genome Med; 2017 Aug; 9(1):74. PubMed ID: 28818087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIOMEDICAL PREVENTION OF HIV IN WOMEN: CHALLENGES AND APPROACHES, WITH PARTICULAR REFERENCE TO THE VAGINAL MICROBIOME.
    Marrazzo JM
    Trans Am Clin Climatol Assoc; 2018; 129():63-73. PubMed ID: 30166700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiome and HIV prevention strategies in women.
    Abdool Karim SS; Passmore JS; Baxter C
    Curr Opin HIV AIDS; 2018 Jan; 13(1):81-87. PubMed ID: 29059077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vaginal microbiota and susceptibility to HIV.
    Buve A; Jespers V; Crucitti T; Fichorova RN
    AIDS; 2014 Oct; 28(16):2333-44. PubMed ID: 25389548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.
    Li SX; Armstrong A; Neff CP; Shaffer M; Lozupone CA; Palmer BE
    Clin Pharmacol Ther; 2016 Jun; 99(6):600-11. PubMed ID: 26940481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal microbiota and its role in HIV transmission and infection.
    Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S
    FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women.
    Klatt NR; Cheu R; Birse K; Zevin AS; Perner M; Noël-Romas L; Grobler A; Westmacott G; Xie IY; Butler J; Mansoor L; McKinnon LR; Passmore JS; Abdool Karim Q; Abdool Karim SS; Burgener AD
    Science; 2017 Jun; 356(6341):938-945. PubMed ID: 28572388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The respiratory microbiome of HIV-infected individuals.
    Lawani MB; Morris A
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):719-29. PubMed ID: 27348261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factors.
    Chehoud C; Stieh DJ; Bailey AG; Laughlin AL; Allen SA; McCotter KL; Sherrill-Mix SA; Hope TJ; Bushman FD
    AIDS; 2017 Apr; 31(7):895-904. PubMed ID: 28121709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome in human immunodeficiency virus infection.
    Salas JT; Chang TL
    Clin Lab Med; 2014 Dec; 34(4):733-45. PubMed ID: 25439273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 12. Sexual networks, HIV, race and bacterial vaginosis.
    Kenyon C; Osbak K
    AIDS; 2015 Mar; 29(5):641-2. PubMed ID: 25710290
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to 'sexual networks, HIV, race and bacterial vaginosis'.
    Buvé A; Fichorova RN
    AIDS; 2015 Mar; 29(5):642-3. PubMed ID: 25710291
    [No Abstract]   [Full Text] [Related]  

  • 14. INFECTIOUS DISEASE. Vaginal microbiome affects HIV risk.
    Cohen J
    Science; 2016 Jul; 353(6297):331. PubMed ID: 27463647
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.
    Vitali D; Wessels JM; Kaushic C
    AIDS Res Ther; 2017 Sep; 14(1):39. PubMed ID: 28893284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Oral Bacterial Communities of Children with Well-Controlled HIV Infection and without HIV Infection.
    Goldberg BE; Mongodin EF; Jones CE; Chung M; Fraser CM; Tate A; Zeichner SL
    PLoS One; 2015; 10(7):e0131615. PubMed ID: 26146997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents.
    Petrova MI; Mathys L; Lebeer S; Noppen S; Van Damme EJ; Tanaka H; Igarashi Y; Vaneechoutte M; Vanderleyden J; Balzarini J
    J Antimicrob Chemother; 2013 Sep; 68(9):2026-37. PubMed ID: 23640125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Start anti-HIV treatment early, in adults and infants.
    Laurence J
    AIDS Read; 2009 Jan; 19(1):6-7, 17. PubMed ID: 19209449
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretrovirals for HIV prevention: when should they be recommended?
    Kiselinova M; De Spiegelaere W; Verhofstede C; Callens SF; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):431-45. PubMed ID: 24621251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal practices, microbicides and HIV: what do we need to know?
    Hilber AM; Chersich MF; van de Wijgert JH; Rees H; Temmerman M
    Sex Transm Infect; 2007 Dec; 83(7):505-8. PubMed ID: 18024709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.